%0 Journal Article
%A Hendricks, Linda A J
%A Verbeek, Katja C J
%A Schuurs-Hoeijmakers, Janneke H M
%A de Jong, Mirjam M
%A Links, Thera P
%A Brems, Hilde
%A Aerden, Mio
%A Brunet, Joan
%A Lleuger-Pujol, Roser
%A Hüneburg, Robert
%A Aretz, Stefan
%A Colas, Chrystelle
%A Villy, Marie-Charlotte
%A Woodward, Emma R
%A Evans, D Gareth
%A Bosch, Daniëlle G M
%A Donze, Stephany H
%A Foretová, Lenka
%A Blatnik, Ana
%A Leter, Edward M
%A Tischkowitz, Marc
%A Jahn, Arne
%A de Putter, Robin
%A Dupont, Juliette
%A Briskemyr, Siri
%A Steinke-Lange, Verena
%A Baldassarri, Margherita
%A Anastasiadou, Violetta C
%A Irmejs, Arvīds
%A Oliveira, Carla
%A van der Post, Rachel S
%A Mensenkamp, Arjen R
%A Tesi, Bianca
%A Mu, Ninni
%A Benusiglio, Patrick R
%A Gerasimenko, Anna
%A Innella, Giovanni
%A Turchetti, Daniela
%A Houdayer, Claude
%A Branchaud, Maud
%A Høberg-Vetti, Hildegunn
%A Haavind, Marianne Tveit
%A Balmaña, Judith
%A Torres, Maite
%A Genuardi, Maurizio
%A Panfili, Arianna
%A Jørgensen, Kjersti
%A Mæhle, Lovise
%A Hoogerbrugge, Nicoline
%A Vos, Janet R
%T The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS).
%J Genetics in medicine
%V 27
%N 10
%@ 1098-3600
%C Amsterdam
%I Elsevier
%M DKFZ-2025-01107
%P 101467
%D 2025
%Z Volume 27, Issue 10, October 2025, 101467
%X Patients with PTEN Hamartoma Tumor Syndrome (PHTS) have high hereditary cancer risks for breast, endometrial, and thyroid cancer. Patients develop multiple primary cancers, but these risks remain uncertain. We aimed to provide the second primary cancer risk.This European cohort study assessed second primary cancer risks with Kaplan-Meier analyses using data from medical files and/or registries.Overall, 279 adult patients with PHTS with cancer were included (80
%K PTEN (Other)
%K PTEN Hamartoma Tumor Syndrome (Other)
%K hereditary cancer (Other)
%K second primary cancer risk (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:40433764
%R 10.1016/j.gim.2025.101467
%U https://inrepo02.dkfz.de/record/301715